BIT 2.22% 4.6¢ biotron limited

The fact the results have not catapulted BIT225 in to front line...

  1. BGI
    1,274 Posts.
    lightbulb Created with Sketch. 118
    The fact the results have not catapulted BIT225 in to front line testing may be a blessing in disguise.
    If the HIV side of business with the clinical trials and partnership goes well, Biotron will become the leading partner in this field and that would be good enough for all shareholders. I know it’s frustrating but …..not long now!
 
watchlist Created with Sketch. Add BIT (ASX) to my watchlist
(20min delay)
Last
4.6¢
Change
0.001(2.22%)
Mkt cap ! $41.50M
Open High Low Value Volume
4.4¢ 4.7¢ 4.4¢ $31.64K 708.3K

Buyers (Bids)

No. Vol. Price($)
4 259000 4.5¢
 

Sellers (Offers)

Price($) Vol. No.
4.6¢ 17361 1
View Market Depth
Last trade - 14.10pm 21/06/2024 (20 minute delay) ?
BIT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.